Welcome Guest ( Log In | Register )

Outline · [ Standard ] · Linear+

 molnupiravir bill will end the pandemic early 2022

views
     
TSCkmwpy0370
post Oct 15 2021, 06:55 PM, updated 3y ago

Look at all my stars!!
*******
Senior Member
3,772 posts

Joined: May 2016

https://www.nature.com/articles/d41586-021-02783-1

https://www.forbes.com/sites/williamhaselti...sh=16f9042c1200

Good news at last!!! Can’t wait!
Retweet:
The World Health Organization (WHO) recently gave an end date for the epidemic: "The pandemic will end in early 2022." Zhang Wenhong also said that the end is not far away.
And the wonder drug was born.
The drug translates as Monapinavir, Developed by Germany's Rigibel and America's Merck, Phase I and phase II clinical trials have been successfully completed in humans with 100% efficacy. Phase 3 clinical trials are nearing completion and the results are excellent. If successful, in 4 to 5 months can be launched. The drug can be taken orally at home and recovered in 5 days. It is very convenient to use. Treating the new coronavirus later is like treating the common cold now.
The drug was originally developed for the flu virus. It's a compound that blocks the viral IA enzyme, which prevents the virus from replicating itself, and essentially destroys the virus very quickly.
The current principle of the vaccine against the new coronavirus is to target the new corona virus's rim, thereby preventing the virus from binding to human cells. The principles are different.
In March and April last year, mink farms in Holland and Norway were infected with new coronavirus, resulting in millions of mink mass deaths. The farm fed the mink with Monapinavir. After 24 hours, no new coronavirus was found in the sick minks, and the farm stopped the transmission of the new virus. Then the two major pharmaceutical companies on the human body to carry out the first phase of clinical trials, after the success of the second phase, the third phase clinical trial, so far is about to officially launch.
All in all, this is a great achievement for the scientific community, especially the medical community. It may be the fourth classic after valium, aspirin and penicillin.  
Developed by Japan's powerful Shiono Yoshi Corporation and Hokkaido University, the new crown drug will be put into production in December, Direct oral once a day, five days cure, very cheap and very safe, has just entered the third phase of clinical trials, the epidemic will eventually end.
jmas
post Oct 15 2021, 07:03 PM

Enthusiast
*****
Junior Member
755 posts

Joined: Mar 2010
another copy paste without checking, no mink farm fed their minks with molnupiravir/Monapinavir

currently this drug still clinical trial in lab only
SUSFenix98
post Oct 15 2021, 07:27 PM

Happy Meal upsized Sir?
***
Junior Member
377 posts

Joined: Jun 2016
Expensive
SUSxander83
post Oct 16 2021, 03:54 AM

Blast off like a rocket
*******
Senior Member
6,427 posts

Joined: Jan 2003
From: Autobiography!!!
QUOTE(Ckmwpy0370 @ Oct 15 2021, 06:55 PM)
https://www.nature.com/articles/d41586-021-02783-1

https://www.forbes.com/sites/williamhaselti...sh=16f9042c1200

Good news at last!!! Can’t wait!
Retweet:
The World Health Organization (WHO) recently gave an end date for the epidemic: "The pandemic will end in early 2022." Zhang Wenhong also said that the end is not far away.
And the wonder drug was born.
The drug translates as Monapinavir, Developed by Germany's Rigibel and America's Merck, Phase I and phase II clinical trials have been successfully completed in humans with 100% efficacy. Phase 3 clinical trials are nearing completion and the results are excellent. If successful, in 4 to 5 months can be launched. The drug can be taken orally at home and recovered in 5 days. It is very convenient to use. Treating the new coronavirus later is like treating the common cold now.
The drug was originally developed for the flu virus. It's a compound that blocks the viral IA enzyme, which prevents the virus from replicating itself, and essentially destroys the virus very quickly.
The current principle of the vaccine against the new coronavirus is to target the new corona virus's rim, thereby preventing the virus from binding to human cells. The principles are different.
In March and April last year, mink farms in Holland and Norway were infected with new coronavirus, resulting in millions of mink mass deaths. The farm fed the mink with Monapinavir. After 24 hours, no new coronavirus was found in the sick minks, and the farm stopped the transmission of the new virus. Then the two major pharmaceutical companies on the human body to carry out the first phase of clinical trials, after the success of the second phase, the third phase clinical trial, so far is about to officially launch.
All in all, this is a great achievement for the scientific community, especially the medical community. It may be the fourth classic after valium, aspirin and penicillin.  
Developed by Japan's powerful Shiono Yoshi Corporation and Hokkaido University, the new crown drug will be put into production in December, Direct oral once a day, five days cure, very cheap and very safe, has just entered the third phase of clinical trials, the epidemic will eventually end.
*
1st ly fake news from CCP as there is spelling errors all around doh.gif

2nd the drug is from Ridgeback Pharma which is based in Florida doh.gif
zher4883
post Oct 16 2021, 09:58 AM

Look at all my stars!!
*******
Senior Member
4,490 posts

Joined: Oct 2014


I had said it and I will say it again. It's a serious conflict of interest when Merck who made both Ivermectin and Molnupiravir telling everyone not to consume Ivermectin and months later issuing press release claiming Molnupiravir work at reducing death without publishing data.
blackamikaze
post Oct 16 2021, 10:07 AM

Trooper Rank: BIG HEAD SERGEANT
*******
Senior Member
2,638 posts

Joined: Jul 2005
From: Bestine, the capital of Tatooine



QUOTE(jmas @ Oct 15 2021, 07:03 PM)
another copy paste without checking, no mink farm fed their minks with molnupiravir/Monapinavir

currently this drug still clinical trial in lab only
*
They give the mink ivermectin. Molnupiravir actually just ivermectin with new name and probably with a higher price tag. The way its work actually very similar to ivermectin.
jmas
post Oct 16 2021, 04:53 PM

Enthusiast
*****
Junior Member
755 posts

Joined: Mar 2010
QUOTE(blackamikaze @ Oct 16 2021, 10:07 AM)
They give the mink ivermectin. Molnupiravir actually just ivermectin with new name and probably with a higher price tag. The way its work actually very similar to ivermectin.
*
again, fact check
QUOTE
QUOTE
The two drugs have “dissimilar chemistry,” he said. “There is no way that Merck is doing this,” he said.

Molnupiravir is a derivative of a nucleotide that, predictably, interferes with the RNA replication of the virus. While Ivermectin does also have a defined mechanism of action, BUT it’s against ion channels found in parasites,” Griffin said.
QUOTE
Ivermectin is classified as a macrocyclic lactone. It is derived from Streptomyces avermitilis which is a bacterium." Molnupiravir, rather, is classified as a nucleoside analog (like some HIV medications) and works as an antiviral

from Reuters


one (Ivermectin) against parasite, another (Molnupiravir) against virus

 

Change to:
| Lo-Fi Version
0.0111sec    0.43    5 queries    GZIP Disabled
Time is now: 28th March 2024 - 09:09 PM